Blog Posts
FDA
FDA Oncology/LinkedIn

FDA Approves the First Oral Treatment for Pheochromocytoma and Paraganglioma – FDA Oncology

FDA Oncology shared a post on X:

“FDA approves the first oral treatment for pheochromocytoma and paraganglioma, rare tumors that form in or outside the adrenal gland.”

More posts featuring FDA Oncology.

Adrenal Gland cancer FDA FDA Oncology fight against cancer Global fight against cancer OncoDaily Oncology oral treatment paraganglioma pheochromocytoma